Carl Zeiss Meditec and Precise Bio to develop fabricated corneal tissue Bioprinting

Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue

Carl Zeiss Meditec, one of the world’s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.